PAK1 confers chemoresistance and poor outcome in non-small cell lung cancer via β-catenin-mediated stemness

[1]  Hwa-Yong Lee,et al.  Blockade of Wnt/β-catenin signaling suppresses breast cancer metastasis by inhibiting CSC-like phenotype , 2015, Scientific Reports.

[2]  Gentao Liu,et al.  Hypoxia-induced cell stemness leads to drug resistance and poor prognosis in lung adenocarcinoma. , 2015, Lung cancer.

[3]  Y. Pan,et al.  p21-activated kinase 1 determines stem-like phenotype and sunitinib resistance via NF-κB/IL-6 activation in renal cell carcinoma , 2015, Cell Death and Disease.

[4]  R. Neve,et al.  PAK1 mediates pancreatic cancer cell migration and resistance to MET inhibition , 2014, Journal of Pathology.

[5]  H. Lee,et al.  Bcl-2 stabilization by paxillin confers 5-fluorouracil resistance in colorectal cancer , 2014, Cell Death and Differentiation.

[6]  K. Seong,et al.  PAK1 tyrosine phosphorylation is required to induce epithelial-mesenchymal transition and radioresistance in lung cancer cells. , 2014, Cancer research.

[7]  S. Chellappan,et al.  Lung cancer stem cells: Molecular features and therapeutic targets. , 2014, Molecular aspects of medicine.

[8]  Amy Brock,et al.  Non-Darwinian dynamics in therapy-induced cancer drug resistance , 2013, Nature Communications.

[9]  D. P. Mishra,et al.  Pharmacological modulation of beta-catenin and its applications in cancer therapy , 2013, Journal of cellular and molecular medicine.

[10]  Dereje D. Jima,et al.  PAK1 Mediates Resistance to PI3K Inhibition in Lymphomas , 2013, Clinical Cancer Research.

[11]  Weihua Jiang,et al.  Role of Wnt/β-catenin signaling in drug resistance of pancreatic cancer. , 2012, Current pharmaceutical design.

[12]  Baiqu Huang,et al.  A Rac1/PAK1 cascade controls β-catenin activation in colon cancer cells , 2012, Oncogene.

[13]  D. Richel,et al.  The developing cancer stem-cell model: clinical challenges and opportunities. , 2012, The Lancet. Oncology.

[14]  Sophia Hsin-Jung Li,et al.  Paracrine and Autocrine Signals Induce and Maintain Mesenchymal and Stem Cell States in the Breast , 2011, Cell.

[15]  A. Harris,et al.  Targeting p21-activated kinase 1 (PAK1) to induce apoptosis of tumor cells , 2011, Proceedings of the National Academy of Sciences.

[16]  G. Baldwin,et al.  P21-activated kinase 1 stimulates colon cancer cell growth and migration/invasion via ERK- and AKT-dependent pathways. , 2010, Biochimica et biophysica acta.

[17]  T. Yau,et al.  A subpopulation of CD26+ cancer stem cells with metastatic capacity in human colorectal cancer. , 2010, Cell stem cell.

[18]  F. Vesuna,et al.  Twist modulates breast cancer stem cells by transcriptional regulation of CD24 expression. , 2009, Neoplasia.

[19]  A. Puisieux,et al.  Generation of Breast Cancer Stem Cells through Epithelial-Mesenchymal Transition , 2008, PloS one.

[20]  Wenjun Guo,et al.  The Epithelial-Mesenchymal Transition Generates Cells with Properties of Stem Cells , 2008, Cell.

[21]  J. Lakins,et al.  α6β4 integrin activates Rac-dependent p21-activated kinase 1 to drive NF-κB-dependent resistance to apoptosis in 3D mammary acini , 2007, Journal of Cell Science.

[22]  C. Heeschen,et al.  Distinct populations of cancer stem cells determine tumor growth and metastatic activity in human pancreatic cancer. , 2007, Cell stem cell.

[23]  Riccardo Fodde,et al.  Wnt/β-catenin signaling in cancer stemness and malignant behavior , 2007 .

[24]  Anupama E. Gururaj,et al.  p21-activated kinases in cancer , 2006, Nature Reviews Cancer.

[25]  K. Jirström,et al.  Association between Pak1 expression and subcellular localization and tamoxifen resistance in breast cancer patients. , 2006, Journal of the National Cancer Institute.

[26]  Thomas Kirchner,et al.  Migrating cancer stem cells — an integrated concept of malignant tumour progression , 2005, Nature Reviews Cancer.

[27]  P. Shaw,et al.  PAK1 primes MEK1 for phosphorylation by Raf-1 kinase during cross-cascade activation of the ERK pathway , 2002, Oncogene.

[28]  John Calvin Reed,et al.  p21-Activated Kinase 1 Phosphorylates the Death Agonist Bad and Protects Cells from Apoptosis , 2000, Molecular and Cellular Biology.

[29]  B. Gandevia,et al.  DECLARATION OF HELSINKI. , 1964, The Medical journal of Australia.

[30]  B. Gandevia,et al.  THE FIRST AUSTRALIAN MEDICAL LIBRARIES , 1964, The Medical journal of Australia.

[31]  DECLARATION OF HELSINKI , 1964 .

[32]  R. Fodde,et al.  Wnt/beta-catenin signaling in cancer stemness and malignant behavior. , 2007, Current opinion in cell biology.

[33]  J. Lakins,et al.  alpha6beta4 integrin activates Rac-dependent p21-activated kinase 1 to drive NF-kappaB-dependent resistance to apoptosis in 3D mammary acini. , 2007, Journal of cell science.